Connect with us

Sci & Tech

US Approves Human Trial For Elon Musk’s Brain Chip Firm Neuralink



Elon Musk’s neurotechnology company Neuralink announced Thursday that it has received approval from the US Food and Drug Administration (FDA) for its first-in-human clinical study of brain implants.

”We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study,” the company said on Twitter.

”This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people.”

It said that recruitment is not yet open for their clinical trial and they will make further announcements soon.

In 2016, Musk co-founded neurotechnology startup Neuralink to integrate the human brain with artificial intelligence (AI) by creating devices embedded in the brain to facilitate its merging with machines.

It is building devices that have the potential to help people with paralysis, the company says on its website.

Kenya Insights allows guest blogging, if you want to be published on Kenya’s most authoritative and accurate blog, have an expose, news TIPS, story angles, human interest stories, drop us an email on [email protected] or via Telegram

Related Content:  Athletes' Speed Will Be Tracked Using Colorful Overlays In Tokyo 2020 Olympics

Most Popular